EXAS - Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics
2024-06-27 17:29:05 ET
More on Exact Sciences
- Exact Sciences: Still No Reason To Own
- Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript
- Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau
- Exact Sciences gains as TD Cowen sees 25% price hike for next-gen Cologuard
- Exact Sciences patent infringement case against Geneoscopy to proceed